Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Income from Continuing Operations (2020 - 2025)

RxSight's Income from Continuing Operations history spans 6 years, with the latest figure at 9152000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 142.63% year-over-year to 9152000.0; the TTM value through Dec 2025 reached 38944000.0, down 79377.55%, while the annual FY2025 figure was 38944000.0, 79377.55% down from the prior year.
  • Income from Continuing Operations reached 9152000.0 in Q4 2025 per RXST's latest filing, up from 9816000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 32960000.0 in Q4 2021 to a low of 17596000.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 7717700.0, with a median of 10801000.0 recorded in 2025.
  • Peak YoY movement for Income from Continuing Operations: plummeted 158.57% in 2022, then soared 333.88% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 32960000.0 in 2021, then tumbled by 147.36% to 15610000.0 in 2022, then skyrocketed by 41.2% to 9179000.0 in 2023, then skyrocketed by 333.88% to 21468000.0 in 2024, then plummeted by 142.63% to 9152000.0 in 2025.
  • Per Business Quant, the three most recent readings for RXST's Income from Continuing Operations are 9152000.0 (Q4 2025), 9816000.0 (Q3 2025), and 11786000.0 (Q2 2025).